Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.

Journal of medical virology - 1 Feb 2001

Pérez-Olmeda M, Del Romero J, Rubio A, Ruiz L, Rodríguez C, Leal M, Clotet B, Soriano V

Abstract excerpt

The prevalence of genotypic resistance to nucleoside analogues was examined in 150 naive individuals with chronic HIV-1 infection acquired before June 1996, when protease inhibitors began to be used in Spain, and in a group of 52 recent seroconverters infected since 1997. Overall, the prevalence of subjects carrying nucleoside-resistant genotypes was similar in both groups (12.6% and 15.4%, respectively). A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease Inhibitors

Share to HIV Seropositivity

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Share to Zidovudine

Source

Identifiers

PMID: 11170042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.PMID 11170042Read ↗

Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.Semantic proximity Read ↗

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.Semantic proximity Read ↗

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainSemantic proximity Read ↗

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.Semantic proximity Read ↗

[Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain].Semantic proximity Read ↗

Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.Semantic proximity Read ↗

Prevalence of genotypic resistance in untreated HIV patients in Spain.Semantic proximity Read ↗

Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in SpainSemantic proximity Read ↗

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.